Search results for "malaria"

Learn how BioApp Solutions enhances liquid handling efficiency with INTEGRA Biosciences' pipettes

The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA

The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster

Join us as we raise awareness of the medical lab profession with a global one day publishing event

Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early